As of today (2026-06-25), Omega Healthcare Investors's share price is R$77.02.
Omega Healthcare Investors's FFO per Share for the trailing twelve months (TTM) ended in Mar. 2026 was R$15.65. Hence, Omega Healthcare Investors's Price-to-Funds-From-Operations Ratio for today is 4.92.
For common stocks, investors use PE ratio, Price to Earnings raio to compare the valuation of different companies. Price-to-Funds-From-Operations ratio is a comparable measure used in the REIT industry. It's a better way to assess whether a REIT is expensive or cheap relative to peers.
Omega Healthcare Investors Price-to-Funds-From-Operations Related Terms
Omega Healthcare Investors Price-to-Funds-From-Operations Historical Data
* Premium members only.
The historical data trend for Omega Healthcare Investors's Price-to-Funds-From-Operations can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:O2HI34 vs DOC, AHR, CTRE: Price-to-Funds-From-Operations Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Price-to-Funds-From-Operations, along with its competitors' market caps and Price-to-Funds-From-Operations data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors Price-to-Funds-From-Operations vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's Price-to-Funds-From-Operations distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's Price-to-Funds-From-Operations falls into.
Omega Healthcare Investors's Share Price of today is R$77.02. Omega Healthcare Investors's FFO per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$15.65.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Price-to-Funds-From-Operations of 4.92 mean?
Omega Healthcare Investors (BSP:O2HI34) has a Price-to-Funds-From-Operations of 4.92 as of Jun. 25, 2026.
Is Omega Healthcare Investors' Price-to-Funds-From-Operations too high?
Omega Healthcare Investors' current Price-to-Funds-From-Operations is 4.92. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Price-to-Funds-From-Operations compare to DOC and AHR?
Omega Healthcare Investors' Price-to-Funds-From-Operations of 4.92 can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Funds-From-Operations for a REITs company?
A good Price-to-Funds-From-Operations depends on the REITs industry context. However, Price-to-Funds-From-Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Funds-From-Operations mean?
A high Price-to-Funds-From-Operations can signal that a stock is expensive relative to its fundamentals. Omega Healthcare Investors's current Price-to-Funds-From-Operations is 4.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Price-to-Funds-From-Operations is 4.92. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Funds-From-Operations calculated?
Price-to-Funds-From-Operations is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Price-to-Funds-From-Operations is 4.92 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
Price-to-Funds-From-Operations: 4.92
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
Price-to-Funds-From-Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
